Pharmacokinetics of Tiotropium in Subjects With COPD

- COPD
- Completed

Study Title: To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Teva Identifier: TBB-COPD-201

ClinicalTrials.gov Identifier: NCT01785433

Study Status: Completed

Trial Condition(s): COPD

Interventions: Drug: Tiotropium HFA BAI 4.5 mcg | Drug: Tiotropium HFA BAI 9.0 mcg | Drug: SPIRIVAֲ® HandiHalerֲ® 18 mcg/day | Drug: Spirivaֲ® Respimatֲ® 5 mcg/day

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 40 Years to 80 Years

Trial Duration: 01/01/2013 - 08/01/2013

Phase: Phase 1/2

Study Type

Interventional